Global Vascular Grafts Market 2022-2026

Description

List of Tables

Technavio has been monitoring the vascular grafts market and it is poised to grow by $ 1.55 bn during 2022-2026, accelerating at a CAGR of 7.22% during the forecast period. Our report on the vascular grafts market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the ubiquity of CVDs and other vascular disorders, a growing shift toward MI techniques, and a high frequency of endovascular aortic repair (EVAR).

The vascular grafts market analysis includes product segment and geographic landscape.

Technavio's vascular grafts market is segmented as below:

By Product

Endovascular grafts

Bypass grafts

Hemodialysis grafts
Peripheral grafts

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological improvements as one of the prime reasons driving the vascular grafts market growth during the next few years. Also, product approvals coupled with R and D activities and emergence of next-generation TEVGs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on vascular grafts market covers the following areas:

Vascular grafts market sizing
Vascular grafts market forecast
Vascular grafts market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular grafts market vendors that include Abbott Laboratories, Artivion Inc., Aruga Technologies, B. Braun Melsungen AG, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, BIOVIC Sdn Bhd, Cardinal Health Inc., Cook Group Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV, InnAVasc Medical Inc., Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lombard Medical Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., Vascular Graft Solutions Ltd., and W. L. Gore and Associates Inc.. Also, the vascular grafts market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72428

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Endovascular grafts - Market size and forecast 2021-2026
Exhibit 28: Chart on Endovascular grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Endovascular grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Endovascular grafts - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Endovascular grafts - Year-over-year growth 2021-2026 (%)
5.4 Bypass grafts - Market size and forecast 2021-2026
Exhibit 32: Chart on Bypass grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Bypass grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Bypass grafts - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Bypass grafts - Year-over-year growth 2021-2026 (%)
5.5 Hemodialysis grafts - Market size and forecast 2021-2026
Exhibit 36: Chart on Hemodialysis grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Hemodialysis grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Hemodialysis grafts - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Hemodialysis grafts - Year-over-year growth 2021-2026 (%)
5.6 Peripheral grafts - Market size and forecast 2021-2026
Exhibit 40: Chart on Peripheral grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Peripheral grafts - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Peripheral grafts - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Peripheral grafts - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Product
Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 93: Abbott Laboratories - Overview
Exhibit 94: Abbott Laboratories - Business segments
Exhibit 95: Abbott Laboratories - Key news
Exhibit 96: Abbott Laboratories - Key offerings
Exhibit 97: Abbott Laboratories - Segment focus
10.4 Artivion Inc.
Exhibit 98: Artivion Inc. - Overview
Exhibit 99: Artivion Inc. - Business segments
Exhibit 100: Artivion Inc. - Key offerings
Exhibit 101: Artivion Inc. - Segment focus
10.5 B. Braun Melsungen AG
Exhibit 102: B. Braun Melsungen AG - Overview
Exhibit 103: B. Braun Melsungen AG - Business segments
Exhibit 104: B. Braun Melsungen AG - Key news
Exhibit 105: B. Braun Melsungen AG - Key offerings
Exhibit 106: B. Braun Melsungen AG - Segment focus
10.6 Becton Dickinson and Co.
Exhibit 107: Becton Dickinson and Co. - Overview
Exhibit 108: Becton Dickinson and Co. - Business segments
Exhibit 109: Becton Dickinson and Co. - Key news
Exhibit 110: Becton Dickinson and Co. - Key offerings
Exhibit 111: Becton Dickinson and Co. - Segment focus
10.7 Cardinal Health Inc.
Exhibit 112: Cardinal Health Inc. - Overview
Exhibit 113: Cardinal Health Inc. - Business segments
Exhibit 114: Cardinal Health Inc. - Key news
Exhibit 115: Cardinal Health Inc. - Key offerings
Exhibit 116: Cardinal Health Inc. - Segment focus
10.8 Cook Group Inc.
Exhibit 117: Cook Group Inc. - Overview
Exhibit 118: Cook Group Inc. - Product / Service
Exhibit 119: Cook Group Inc. - Key offerings
10.9 LeMaitre Vascular Inc.
Exhibit 120: LeMaitre Vascular Inc. - Overview
Exhibit 121: LeMaitre Vascular Inc. - Product / Service
Exhibit 122: LeMaitre Vascular Inc. - Key offerings
10.10 Medtronic Plc
Exhibit 123: Medtronic Plc - Overview
Exhibit 124: Medtronic Plc - Business segments
Exhibit 125: Medtronic Plc - Key news
Exhibit 126: Medtronic Plc - Key offerings
Exhibit 127: Medtronic Plc - Segment focus
10.11 Terumo Corp.
Exhibit 128: Terumo Corp. - Overview
Exhibit 129: Terumo Corp. - Business segments
Exhibit 130: Terumo Corp. - Key news
Exhibit 131: Terumo Corp. - Key offerings
Exhibit 132: Terumo Corp. - Segment focus
10.12 W. L. Gore and Associates Inc.
Exhibit 133: W. L. Gore and Associates Inc. - Overview
Exhibit 134: W. L. Gore and Associates Inc. - Product / Service
Exhibit 135: W. L. Gore and Associates Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations